The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Preliminary ProgramFull Access

Preliminary Program: Monday May 20

Published Online:https://doi.org/10.1176/pn.37.4.0015

7 a.m.-8:30 a.m.

Industry-Supported Breakfast Symposia

IS25. Clinical Challenges in Depression (Part 1) Supported by GlaxoSmithKline

A. Special Challenges in Treating Bipolar Depression and Psychotic Depression David V. Sheehan, M.D.

B. Growing Up Depressed: The Underserved Child and Adolescent Neal D. Ryan, M.D.

C. Cardiovascular Disease and Depression: A Deadly Comorbidity Dominique L. Musselman, M.D.

IS26. Novel Antipsychotic Drugs: Advances in the Treatment of Psychotic Spectrum Disorders (Part 1) Supported by Bristol-Myers Squibb Company

A. Bench to Bedside: Rational Selection of Medications in Treating Schizophrenia Rona Hu, M.D.

B. What We Have Learned About the Long-Term Management of Schizophrenia: What Constitutes Treatment Refractoriness? John M. Kane, M.D.

IS27. Antipsychotic Pharmacotherapy and the Hippocratic Oath: Above All Do No Harm (Part 1) Supported by AstraZeneca Pharmaceuticals

A. Medical Morbidity and Mortality in Patients With Schizophrenia S. Charles Schulz, M.D.

B. Minimizing Acute and Long-Term Movement Disorders With Atypical Antipsychotics Lilli Kopala, M.D.

C. Weight Gain and Obesity Secondary to Atypicals: Immediate and Long-Term Health Threats Diana O. Perkins, M.D.

IS28. Understanding Sleep Medicine: What the Psychiatrist Needs to Know (Part 1) Supported by Wyeth-Ayerst Laboratories

A. Mechanism of Action of Hypnotics Stephen M. Stahl, M.D.

B. Sleep Disorders: What the Psychiatrist Needs to Know Lois Krahn, M.D.

C. Morbidity of Insomnia Thomas Roth, Ph.D.

IS29. One Size Doesn’t Fit All: Depression Therapies for the 21st Century (Part 1) Supported by Eli Lilly and Company

A. The Physical Manifestations of Depression John Griest, M.D.

B. Improving Outcomes in the Long-Term Treatment of Depression: Giving Patients a Choice Maurizio Fava, M.D.

C. Lost in Depression: The Treatment-Resistant Patient Holly A. Swartz, M.D.

IS30. Breaking the Silence of Children’s Mental Illness: National Initiatives, Early Detection, and New Pharmacotherapies (Part 1) Supported by Janssen Pharmaceutica

A. Mental Illness in Children: Diagnosing Outside the Box Hans Steiner, M.D.

B. Atypical Antipsychotics in Pediatric Psychiatry: Efficacy in Well-Designed Trials Christopher J. McDougle, M.D.

C. Diagnostic and Therapeutic Issues in the Management of Pediatric-Onset Bipolar Disorder Janet Wozniak, M.D.

Residents’ Session: Meet the Experts: Sunny-Side Up

7:30 a.m.-6 p.m.

Registration/Course Enrollment Open

8 a.m.-Noon

CME Courses 39-44

9 a.m.-10:30 a.m.

Clinical Case Conference 1. Lynda A. Tenhundfeld, M.D., on Contrasting Psychopathology in Adolescents and Adults (Open to APA members only.)

Discussion Groups

1. Jonathan F. Borus, M.D., on Writing for Publication in the Professional Literature

2. Leslie H. Gise, M.D., on Save Time, Make Money, Have Fun! Outpatient Group Therapy for the Seriously Mentally Ill

3. Lenore C. Terr, M.D., on What Makes People Change?

4. Kelly L. Cozza, M.D., and Scott C. Armstrong, M.D., on Quickie Guide to the Cytochrome P450 System (Meet the Authors)

5. Nehama Dresner, M.D., on Postpartum Depression: Prevention and Intervention

Lectures

L2. Personality Disorders: New Findings and Current Controversies John M. Oldham, M.D., Distinguished Psychiatrist Lecture Series

L3. Accessing Care: A Challenge to the Poor and Disadvantaged Pedro Ruiz, M.D., APA’s George Tarjan Award Lecture

Master Educator Clinical Consultations

1. Elissa P. Benedek, M.D., on Child Forensic Psychiatry Contemporary Issues (Open to APA members only.)

2. Francine Cournos, M.D., on The Aftermath of Childhood Parental Loss (Open to APA members only.)

Media Sessions

Session 3. American Frenzy

3. Time Frenzy

Session 4. Puppetry of Personality

4. The Puppets of Di Cori: New Psychodrama Approach

New Research Young Investigators’ Poster Session 1

Roundtable Discussion

Government Response to Terrorism Moderator: Randall D. Marshall, M.D.

Component Workshops

CW1. How to Convince Corporate CEOs that Mental Health Is a Good Investment APA Committee on APA/Business Relationships Co-Chairpersons: Norman A. Clemens, M.D., Lloyd I. Sederer, M.D.

CW2. Justice and Health Equity in Global Psychiatry APA Commission on Global Psychiatry Chairperson: Arthur M. Kleinman, M.D.

CW3. The American Psychiatric Association and Its Alliance Go to America’s Schools APA Alliance Chairperson: Alicia A. Muñoz, B.S.C.

CW4. When Your Physician Patient Is From an Ethnic Minority: A Cross-Cultural Approach to Treatment APA Committee on Physician Health, Illness, and Impairment Co-Chairpersons: Carmen T. Webb, M.D., Patti Tighe, M.D.

CW5. The Psychiatrist and Migration in the 21st Century APA Rhode Island Psychiatric Society Co-Chairpersons: Shahbaz A. Khan, M.D., Thomas O. Osinowo, M.D.

CW6. Risk Management Issues in Psychiatric Practice APA Psychiatrists’ Purchasing Group Inc. Chairperson: Alan I. Levenson, M.D.

CW7. The Philadelphia Story: A VA University of Addiction Research Collaboration APA Consortium on Organized Service Systems Chairperson: Laurent S. Lehmann, M.D.

CW8. Substance Abuse in Special Populations APA Council on Addiction Psychiatry Chairperson: Ramon Solhkhah, M.D.

CW9. Aging and Mourning in the Gay and Lesbian Community APA New York County District Branch’s Committee on Gay and Lesbian Issues Co-Chairpersons: Benjamin H. McCommon Jr., M.D., Jordan F. Karp, M.D.

CW10. Psychiatry in the Neuroscience Curriculum: Promise and Peril APA Committee on Medical Student Education Chairperson: Carl B. Greiner, M.D.

CW11. The Role of the Geriatric Psychiatrist in Palliative Care APA Committee on Access and Effectiveness of Psychiatric Services for the Elderly Chairperson: Judith H. W. Crossett, M.D.

Issue Workshops

IW1. How to Get the Most Out of Supervision: What Residents Need to Know Chairperson: Sarah M. Whitman, M.D.

IW2. Nursing Home Psychiatry: Problems and Solutions Chairperson: Marc I. Rothman, M.D.

IW3. Cognitive-Behavioral Therapy Training for Residents: How to Teach, Measure, and Attain Resident Competency Chairperson: Donna M. Sudak, M.D.

IW4. Supervision 101: Sex, Lies, and Videotape? Chairperson: Chelsea L. Chesen, M.D.

IW5. Children of Psychiatrists: 21st-Century Insights Co-Chairpersons: Leah J. Dickstein, M.D., Michelle B. Riba, M.D.

IW6. The Policing of Physician-Patient Boundaries: Some International Perspectives Chairperson: Gail E. Robinson, M.D.

IW7. Personality Disorders in the Mental Retardation and Development Disorders Population Co-Chairpersons: Harvey Stabinsky, M.D., Susan Stabinsky, M.D.

IW8. The Impact on Clinicians of Suicide Co-Chairpersons: Eric M. Plakun, M.D., Jane G. Tillman, Ph.D.

IW9. Career Development for International Medical Graduates Chairperson: Renato D. Alarçon, M.D.

IW10. Evaluation of Telepsychiatry Services in an Integrated Hospital System in the Department of Veterans Affairs and Department of Defense Co-Chairpersons: Paul E. Ruskin, M.D., Stephen J. Cozza, M.D.

IW11. Access to Psychotherapy Training in Residency: A Current Perspective Chairperson: Robert W. Guynn, M.D.

IW12. Use of the Personal Digital Assistant in Psychiatry Psychiatric Society of Informatics Chairperson: John Luo, M.D.

IW13. Schizophrenia With Comorbid Conditions: Clinical and Research Issues Co-Chairpersons: Michael Y. Hwang, M.D., Miklos F. Losonczy, M.D.

IW14. Psychotherapy Training for the 21st-Century Psychiatrist Co-Chairpersons: Diane M. Roston, M.D., Rebecca R. Neal, M.D.

IW15. Training a Culturally Competent Psychiatric Workforce Co-Chairpersons: Janet E. Osterman, M.D., Albert C. Gaw, M.D.

IW16. Transgender Care: New Perspectives Chairperson: Dan H. Karasic, M.D.

IW17. How to Effectively Integrate Mental Health Services in General Care Systems Chairperson: Ann Marie T. Sullivan, M.D.

IW18. Breaking the Cycle of Maternal Addiction: An Integrated Treatment Program Making a Difference Chairperson: Cynthia C. Crone, A.P.N.

9 a.m.-Noon

Continuous Clinical Case Conference James W. Lomax II, M.D.,Glen O. Gabbard, M.D., and Irma J. Bland, M.D., on Lives and Treatments: Two Patients, Two Therapists (Part I) (Open to APA members only.)

S1. Evidence-Based Psychodynamic Therapy Part I: Studying Clinical Work American Academy of Psychoanalysis and American Psychoanalytic Association

A. The Analytic Process Scales II: Intervention Quality and Patient Productivity Sherwood Waldron Jr., M.D.

B. The Analytic Process Scales Anna M. Burton, M.D.

C. An Outcome Study for Psychodynamic Psychotherapy of Panic Disorder Barbara L. Milrod, M.D.

9 a.m.-4 p.m.

CME Courses 45-50

10 a.m.-6 p.m.

Exhibits Open

Publishers’ Bookfair Open

APA Resource Center Open

10:30 a.m.-12:30 p.m.

Research Advances in Psychiatry: Understanding the Brain and Body in the Treatment of Depression and Schizophrenia APA Scientific Program Committee and APA Council on Research Chairperson: Herbert Pardes, M.D. Co-Chairperson: Philip R. Muskin, M.D.

11a.m.-12:30 p.m.

Discussion Groups

6. Glen O. Gabbard, M.D., on Psychodynamic Psychiatry in Clinical Practice: Third Edition (Meet the Authors)

7. William Breitbart, M.D., on Psychiatry and Palliative Medicine

8. Charles E. Schwartz, M.D., on Working With HIV-Positive Patients and Their Physicians

9. Brian A. Fallon, M.D., on Recognizing and Treating Neuropsychiatric Lyme Disease

Lectures

L4. Neuroscience in the New Millennium Gerald D. Fischbach, M.D.,Frontiers of Science Lecture Series

L5. Opioids and Single-Nucleotide Polymorphisms: Implications for Heroin and Cocaine Addictions Mary Jeanne Kreek, M.D.,Frontiers of Science Lecture Series

Master Educator Clinical Consultations

3. Allan Tasman, M.D., on the Doctor-Patient Relationship in Pharmacotherapy (Open to APA members only.)

4. Salman Akhtar, M.D., on Psychotherapy With Immigrant Patients (Open to APA members only.)

Medical Update 1. Stephen C. Silberstein, M.D., on Migraine: Diagnosis, Treatment, and Comorbidity

Scientific and Clinical Report Sessions

Session 1. Anxiety Disorders

2. Switching From Imipramine to Sertraline in Panic Disorder With Agoraphobia Matig R. Mavissakalian, M.D.

3. Atypical Depression in Primary Anxiety Disorders Michael A. Van Ameringen, M.D.

4. Risk Factors for PTSD in North Korean Defectors Wootaek Jeon, M.D.

Session 2. Eating Disorders

5. Perfectionism, Training, and Eating Behaviors in Runners Jason M. Andrus, M.D.

6. Self-Reported Hunger and Parasympathetic Tone Alayne Yates, M.D.

7. Topiramate Treatment of Bulimia Nervosa Scott P. Hoopes, M.D.

Session 3. Consultation-Liaison Psychiatry

8. Mixed Anxiety Depressive Disorder in a Sample of Primary Care Patients Risa B. Weisberg, Ph.D.

9. Psychopathological Aspects in 86 Chronic Fatigue Syndrome Patients Massimo di Giannantonio, M.D.

10. Low Expression of Negative Affect and Denial Predict Breast Cancer Recurrence Karen L. Weihs, M.D.

Session 4. Issues in Cross-Cultural Psychiatry

11. Is the Wechsler Intelligence Scale for Children, Third Edition (WISC-III UK), Applicable to Ghana? Ama K. Edwin, M.B.

12. Dissociation, Childhood Trauma, and Ataque De Nervios Roberto Lewis-Fernandez, M.D.

13. Trauma, Creative Cognition, and Success Among Tribal South-African Students Albert Rothenberg, M.D.

Session 5. Issues in Mid-Life and Beyond

14. Long-Term Effects of Depression on Symptoms and Function in Mid-Life Women Joyce T. Bromberger, Ph.D.

15. Socioeconomic Status and Depression Among Older Adults John Cairney, M.A.

16. Psychotherapy With the Elderly Daniel A. Plotkin, M.D.

Session 6. Psychopharmacology of Mood Disorders

17. Fluoxetine-Induced Weight Change in Depressive Subtypes Christina M. Dording, M.D.

18. Adjunct Modafinil for Fatigue and Wakefulness in MDD Karl Doghramji, M.D.

19. Short-Term Use of Estradiol as an Antidepressant Strategy in Perimenopausal and Postmenopausal Women Lee S. Cohen, M.D.

Session 7. Management of Bipolar Disorder

20. A Comparison of the Prevalence and Correlates of Anger Attacks in Bipolar Disorder Roy H. Perlis, M.D.

21. Topiramate Treatment of Rapid-Cycling Mood Disorder Mohammad Z. Hussain, M.D.

22. Cognitive and Psychosocial Deficits in Bipolar Disorder and Schizophrenia Joseph Ventura, Ph.D.

Session 8. Suicide

23. Suicides in Youths Involved With Juvenile Justice and Child Welfare Services Johanne Renaud, M.D.

24. Predictors of Suicide Attempts in a Personality Disorder Sample Shirley Yen, Ph.D.

25. Hostility and Impulsivity Among Suicidal Bipolar Patients Benjamin H. Michaelis, M.A.

Session 9. BPD

26. BPD, Medical Illness, Lifestyle Choices, and Health Care Utilization Frances R. Frankenburg, M.D.

27. Impulsivity, Gender, and 5HT in BPD Paul H. Soloff, M.D.

28. Diagnostic Efficiency of BPD and Antisocial Personality Disorder (APD) Criteria in Monolingual Hispanic Men Daniel F. Becker, M.D.

Session 10. Topics in Schizophrenia

29. The Relationship Between Negative and Positive Symptoms: A 15-Year Follow-Up Martin Harrow, Ph.D.

30. Neurological Soft Signs and Psychopathology in Schizophrenia Giuseppe Bersani

31. Heterogeneity in Schizophrenia: Cognitive Deficits and Brain Abnormalities Bruce E. Wexler, M.D.

Session 11. Olanzapine: Bipolar Disorders and Agitation

32. Effectiveness of Rapid Initial Dose Escalation of Oral Olanzapine for Acute Agitation Robert W. Baker, M.D.

33. Olanzapine Combined With Lithium or Valproate for Relapse Prevention of Bipolar Disorder: An 18-Month Study Mauricio F. Tohen, M.D.

34. Olanzapine Versus Divalproex Sodium for Mania: A 47-Week Study Robert W. Baker, M.D.

Session 12. Health Services Research

35. Consensus Development on Core Quality Measures for Mental Health Care Richard C. Hermann, M.D.

36. Improving the Competency of Clinicians Treating People With Mental Illness Alexander S. Young, M.D.

Component Workshops

CW12. Navigating Geriatric Psychiatry Research: Issues for the Beginning Researcher APA Committee on Ethnic Minority Elderly and APA Council on Aging Chairperson: Josepha A. Cheong, M.D.

CW13. Experts or Pawns? Psychiatric Consultation for Government Agencies APA Committee on Misuse and Abuse of Psychiatry and Psychiatrists Chairperson: Robert P. Cabaj, M.D.

CW14. Legal and Psychiatric Controversies in Interferon Treatment of Hepatitis C APA New York County District Branch’s AIDS Committee Co-Chairpersons: Kristina L. Jones, M.D., Scott Burris, J.D.

CW15. The Good-Enough Mentor: Perspectives on Mentoring in Psychiatric Training APA/GlaxoWellcome Fellows Chairperson: Paul E. Holtzheimer III, M.D.

CW16. Talking on Your Feet: Survival Tips and Techniques for Media Interviews APA Joint Commission on Public Affairs Co-Chairpersons: Michael Blumenfield, M.D., Sandra C. Walker, M.D.

CW17. Psychiatry Without Borders: Breaking the Barriers APA Committee on International Medical Graduates Co-Chairpersons: Gopalakrishna K. Upadhya, M.D., Godehard Oepen, M.D.

CW18. Psychiatric Casualties in the Mental Health of Hispanic Immigrants APA Committee of Hispanic Psychiatrists Co-Chairpersons: Ana E. Campo, M.D., Eugenio M. Rothe, M.D.

Issue Workshops

IW19. Treating Psychosis Across Diagnosis Chairperson: Lewis A. Opler, M.D.

IW20. Challenges of the Chief Resident in Psychiatry Chairperson: Sadiq H. Al-Samarrai, M.D.

IW21. Nonsexual Boundary Violations: Special Problems in Small Communities Chairperson: Malkah T. Notman, M.D.

IW22. Cognitive Therapy for Personality Disorders Chairperson: Judith S. Beck, Ph.D.

IW23. Assessing Psychotherapy Competencies of Residents Chairperson: Joel Yager, M.D.

IW24. Professionalism in the Teacher/Learner Relationship Chairperson: Alison M. Heru, M.D.

IW25. Psychotherapy Termination: A Challenge in Psychiatric Residency Training Chairperson: Anu A. Matorin, M.D.

IW26. Confidentiality Issues and Legal Essentials in Sexual Harassment Cases Co-Chairpersons: Rita R. Newman, M.D., Annette J. Hollander, M.D.

IW27. Pseudodementia in the 21st Century Chairperson: Maurice Preter, M.D.

IW28. What Works in Substance Abuse Treatment? Substance Abuse and Mental Health Services Administration Chairperson: A. Thomas McLellan, Ph.D.

11 a.m.-2 p.m.

Media Sessions

Session 5. Cultural Collisions

5. Carved From the Heart: A Portrait of Grief, Healing, and Community

6. Homeland

7. Between Worlds

Session 6. Images in Black and White

8. M & M Smith: For Prosperity’s Sake

Noon-1:30 p.m.

Forums

1. The Mental Health Community Response to the World Trade Center Disaster Chairperson: Randall D. Marshall, M.D.

2. Leadership Challenges in Mental Health and Substance Abuse: A Meeting of the Minds Substance Abuse and Mental Health Services Administration Chairperson: Charles Curie

3. Evil Chairperson:Samuel C. Klagsbrun, M.D.

4. Music and Mood Disorders: Tchaikovsky Chairperson: Richard Kogan, M.D.

12:30 p.m.-2 p.m.

Media Session

Session 7. When Not to Keep a Secret

9. In the Mix APA Alliance

1 p.m.-2:30 p.m.

New Research Young Investigators’ Oral/Slide Sessions 2-4

1 p.m.-5 p.m.

CME Courses 51-56

2 p.m.-3:30 p.m.

Lecture

L6. Alzheimer’s Disease: The Challenges of Big Risks and Small Gains Richard Mayeux, M.D., Frontiers of Science Lecture Series

2 p.m.-5 p.m.

Media Sessions

Session 8. Transgender Trials

10. Southern Comfort

11. Just Call Me Kade

Session 9. Mob Mentality: The Analysis of Tony Soprano

12. Sopranos

Presidential Symposium

What Will the 21st Century Bring to the Training of Psychiatrists? Chairperson: Lisa A. Mellman, M.D., Co-Chairperson: Ronald O. Rieder, M.D.

Symposia

S2. Advances in the Diagnosis and Treatment of Delirium

A. The Experience of Delirium in Cancer Patients William Breitbart, M.D.

B. The Clinical Diagnosis of Delirium John W. Barnhill, M.D.

C. Clinical Utility and Cost-Benefit Profile of Diagnostic Testing in Delirium Christopher I. Kauffman, M.D.

D. The Use of Atypical Antipsychotics in the Treatment of Delirium Stephen J. Ferrando, M.D.

E. An Open Trial of Olanzapine in the Treatment of Delirium William Breitbart, M.D.

S3. Plagues, Prions, and Paranoia: The Neuropsychiatry of Infectious Disease

A. Psychiatric and Cognitive Features of Lyme Disease Felice A. Tager, Ph.D.

B. Regional Specificity and the Neuropathophysiology of HIV-1 in Brain Karl Goodkin, M.D.

C. The Neuropsychiatry of the Transmissible Spongiform Encephalopathies David N. Irani, M.D.

D. Psychiatric Manifestations of Acute Viral Encephalitis Stanley N. Caroff, M.D.

E. Neurosyphilis: A History and Clinical Review Michael F. Gliatto, M.D.

S4. Fear and Loathing in the Medication Clinic APA Commission on Psychotherapy by Psychiatrists

A. To Monitor or to Relate? Jerald Kay, M.D.

B. Split-Treatment Angst Michelle B. Riba, M.D.

C. The Divided Hour: Psychotherapy in the Medication Check and Other Brief Sessions Jesse H. Wright, M.D.

S5. Health Insurance Portability and Accountability Act: Clinical Applications and Implications

A. Basic Health Insurance Portability and Accountability Act Overviews Norman E. Alessi, M.D.

B. Confidentiality and Security Concerns Under the Health Insurance Portability and Accountability Act Charles J. Rainey, M.D.

C. Data Protection in Practice: The Impact of the Data Protection Act and Other Legislation in the United Kingdom Brian Lunn, M.D.

S6. Eating Disorders 2002: Biological, Clinical, and Social Perspectives

A. Trait-Related 5HT 1A Disturbances in Anorexia Nervosa: Relationship to Susceptibility Walter H. Kaye, M.D.

B. Who’s Dying From an Eating Disorder? David B. Herzog, M.D.

C. The Role of the Dentist in the Care of Eating-Disorder Patients James E. Mitchell, M.D.

D. Primary Prevention of Eating Disorders: A Tale of Two Countries Katherine A. Halmi, M.D.

E. E-Technologies and Eating Disorders: Problems and Prospects Joel Yager, M.D.

S7. Management of Schizophrenia With Comorbid Disorders

A. Management of Schizophrenia With Depression Samuel G. Siris, M.D.

B. Management of Schizophrenia With Comorbid Anxiety Disorders Michael Y. Hwang, M.D.

C. Clinical Management of Persistent Aggressive Behavior in Schizophrenia Leslie L. Citrome, M.D.

D. Long-Term Outcome and Comorbid Conditions: Why Do We Know So Little? Nina R. Schooler, Ph.D.

S8. Depressive Spectrum Disorder in Late Life: Implications for Clinical Care

A. Nonmajor Clinically Significant Depression: The Existing Evidence of a Continuum Anand Kumar, M.D.

B. Clinical Features of a Depressive Continuum George S. Alexopoulos, M.D.

C. Dysthymic Disorder in the Elderly Davangere P. Devanand, M.D.

D. Depression and Symptomatic Anxiety Alastair J. Flint, M.B.

S9. Interaction of Stress and Personality Association for Research in Personality Disorders

A. Stress and Personality: Biological Implications Kenneth R. Silk, M.D.

B. Clinical Characteristics of Stress-Induced Personality Disorders James H. Reich, M.D.

C. Relationship Between Adjustment, Anxiety, and Depressive Disorders Peter Tyrer, M.D.

D. Job Stress Among Young Physicians: Working Conditions or Personality, A Prospective Study Per Vaglum, M.D.

E. Schema-Focused Cognitive Therapy and Stress-Exacerbated Personality Disorders David P. Bernstein, Ph.D.

S10. Evidence-Based Psychodynamic Therapy Part II: What Do the Data Show? American Academy of Psychoanalysis and American Psychoanalytic Association

A. The Benefits of Individual Psychotherapy for Schizophrenia Patients: A Meta-Analytic Review William H. Gottdiener, Ph.D.

B. Controlled Trials of Psychoanalytic Therapies for Young People Peter Fonagy, Ph.D.

C. The Limited Effectiveness of Short-Term Therapy for Anorexia Nervosa Authur L. Robin, Ph.D.

D. Randomized Clinical Trial of a Psychoanalytic Treatment of BPD Anthony Bateman, M.D.

S11. Social Psychiatric Aspects of Violence and Trauma American Association for Social Psychiatry

A. Trauma and Violence: A U.S. Perspective Carl C. Bell, M.D.

B. Social Aspect of Trauma S. Arshad Husain, M.D.

C. Nostalgia as a Defense Against Fully Experiencing the Trauma of Immigration Salman Akhtar, M.D.

D. Consequences of Psychosocial Interventions: The Potential to Harm and Help Daniel L. Creson, M.D.

E. PTSD and Cultural Competency Edward F. Foulks, M.D.

S12. Sadistic Personality Disorder: Its Wide Range and Importance as a Diagnosis

A. Sadism and Forensic Psychiatry Michael M. Welner, M.D.

B. Sadistic Personality Disorder: The Need to Reinstate in Future Editions of DSMMichael H. Stone, M.D.

C. Sadistic Behaviors and Victim Response Ann Burgess, D.N.

D. The Empirical Relationship Between Psychopathy and Sadism J. Reid Meloy, Ph.D.

S13. From Research to Practice: Primary Care Research in Substance Abuse and Mental Health Services for Elderly (PRISMe) Substance Abuse and Mental Health Services Administration

A. Integration of Mental Health and Substance Abuse Services in Primary Care for the Elderly John S. McIntyre, M.D.

B. Consumers’ and Researchers’ Perspective on Improving Elderly Asian-Americans’ and Hispanic-Americans’ Participation in Mental Health and Substance Abuse Research Hongtu Chen, Ph.D.

C. Consumers and Researchers: New Partnership Challenges and Opportunities Cynthia Zubritsky, Ph.D.

D. Identification and Treatment of Alcohol Problems in Primary Care David W. Oslin, M.D.

E. Health Policy Implications of (PRISMe) and the Promise of Research on Mental Health and Substance Abuse Treatment of Older Persons in Primary Care Stephen J. Bartels, M.D.

S14. Extinction Versus Adaptation: The Future of State Hospital Psychiatry APA Caucus of State Hospital Psychiatrists and American Association of Psychiatric Administrators

A. Building, Unbuilding, and Rebuilding America’s State Hospitals Jeffrey L. Geller, M.D.

B. The Future of State Hospital Psychiatry Part II: Surviving Political Changes Thomas W. Hester, M.D.

C. Recruitment and Retention Joel S. Feiner, M.D.

D. Medical Leadership in State Hospital Systems Christopher G. Fichtner, M.D.

S15. The Social Brain and Psychotherapy World Psychiatric Association

A. Clinical Sociophysiology Russell J. Gardner Jr., M.D.

B. Sociodynamics in Psychotherapy John O. Beahrs, M.D.

C The Social Brain as Site of Truth and Deception Godehard Oepen, M.D.

D. Biology of Family Psychotherapy Douglas A. Kramer, M.D.

E. A Skeptic’s View of Bridging Efforts Alan A. Stone, M.D.

S16. Special Topics in Women’s Mental Health

A. Mood Disturbance and Pregnancy: Pros and Cons of Pharmacological Treatment Adele C. Viguera, M.D.

B. Psychiatric Characteristics of Binge-Eating Disorder in Obese Women Jose C. Appolinario, M.D.

C. Gender and Addiction: What Is New? Monica L. Zilberman, Ph.D.

D. Impact of Estrogen and Other Sexual Hormones on Mood Disturbances Claudio N. Soares, M.D.

E. Estrogens and Alzheimer’s Disease in Elderly Women Monica Z. Scalco, M.D.

S17. Practicing Psychiatry in 2002

A. The Minnesota Physician-Patient Alliance Lee H. Beecher, M.D.

B. Solo Practice Psychiatry in the Community Thomas W. Dodson, M.D.

C. Brain and Mind in Clinical Practice Ronald D. Abramson, M.D.

D. Psychiatry in the 21st Century Garry M. Vickar, M.D.

E. Practicing Public Psychiatry in the 21st Century Roger Peele, M.D.

F. General Hospital Psychiatry for the Future John C. Urbaitis, M.D.

G. Practicing Psychiatry Today With Enjoyment and Integrity Despite Managed Care Brian Crowley, M.D.

S18. Love From Pathology to Normality

A. Change of Heart Between Attachment Network and Romantic Love in Arranged Marriages Danielle Groleau, Ph.D.

B. Clinical Considerations About Pedophilia: Love, Sex, and Transgressions Roland M. Coutanceau, M.D.

C. The Love Life of Melancholics Peter D. Kramer, M.D.

D. Skin Deep: Transsexuality, Gender Identity, and the Psychopathology of Love Nancy M. Blake, Ph.D.

E. Love as a Mirror of Human Distress: A Transcultural Perspective Richard Rechtman, M.D.

S19. Adolescence: The Tumultuous Years

A. Meeting the Needs of Students Exposed to Violence Through School-Based Programs Bradley D. Stein, M.D.

B. Adolescent Alcohol and Drug Abuse: Challenges and Transitions Sandra A. Brown, Ph.D.

C. Treatment Implications of Teen-Onset Mania Gabrielle Carlson, M.D.

D. Diagnosis and Treatment of Dysthymia and Double Depression David L. Dunner, M.D.

S20. Is There a Bipolar Spectrum?

A. The Validity of the Bipolar Spectrum Hagop S. Akiskal, M.D.

B. Predictors of Unipolar to Bipolar Conversion in Affective Disorders Joseph F. Goldberg, M.D.

C. The Bipolar Spectrum: The Clinician’s View Jacob J. Katzow, M.D.

D. Criticism of the Bipolar Spectrum as a Concept S. Nassir Ghaemi, M.D.

S21. Update on Treatment of Stimulant Abuse

A. Recovery-Oriented Psychosocial Treatments Douglas M. Ziedonis, M.D.

B. Therapy and Placement Approaches for Cocaine-Abuse Treatment David R. Gastfriend, M.D.

C. Pharmacological Treatment of Stimulant Abuse David A. Gorelick, M.D.

D. Psychiatric Comorbidity in Stimulant Abusers Richard N. Rosenthal, M.D.

E. Methamphetamine Abuse: 2002 Update Steven L. Batki, M.D.

S22. New Frontiers in the Neuroendocrinology of Affective Disorders

A. Assessing Vulnerability to Depression: Role of HPA Axis Dysfunction D. Jeffrey Newport, M.D.

B. Gender Differences in Thyroid Indices in Depression Mark A. Frye, M.D.

C. Testosterone and Depression in Men: A Clinical Review Stuart N. Seidman, M.D.

D. Estrogen Use, Mood, and Cerebral Metabolism in Menopausal Women Natalie L. Rasgon, M.D.

S23. Addictions: Cutting-Edge Treatments for Gambling and Substance Abuse

A. Treatment of Cocaine Dependence Adam M. Bisaga, M.D.

B. Treatment of Heroin Dependence Herbert D. Kleber, M.D.

C. Marijuana and Club Drugs: Cutting-Edge Developments, New and Potential Treatments David M. McDowell, M.D.

D. Cutting-Edge Treatment of Gambling Addiction Eric Hollander, M.D.

E. Treatment of Comorbid Conditions Frances R. Levin, M.D.

S24. Psychotherapy Research: Challenges for the 21st Century

A. Patient Response to the Brief Psychodynamic Investigation Jean-Nicolas Despland, M.D.

B. Matching Patients to Therapy: A Review of Empirical Studies of Psychotherapy Per A. Hoglend, M.D.

C. Moving Cognitive Therapy From the Research Clinic to General Psychiatric Practice Robert J. DeRubeis, Ph.D.

D. Are Recovery and Healthy Functioning Achievable Treatment Goals for Axis II Disorders? John C. Perry, M.D.

E. Long-Term Psychotherapy: Current Status and Future Directions Paul Crits-Christoph, Ph.D.

S25. A Research Agenda for DSM-V

A. Nomenclature Recommendations Bruce J. Rounsaville, M.D.

B. Neuroscience Recommendations Dennis S. Charney, M.D.

C. Developmental Recommendations Daniel Pine, M.D.

D. Disability and Impairment Recommendations Anthony F. Lehman, M.D.

E. Cross-Cultural Recommendations Renato D. Alarçon, M.D.

F. Gaps in the Current System: Recommendations Michael B. First, M.D.

S26. Academic and Community Mental Health: Can This Marriage Be Saved? American Association of Community Psychiatrists

A. Public Academic Liaison: Can This Marriage Be Saved? Anita Everett, M.D.

B. How Do You Keep Them Down on the Farm? Training, Recruitment, and Retention Barbara M. Rohland, M.D.

C. UC Davis and Sacramento County: A Shotgun Wedding Turned Shared Vision for Public Mental Health Thomas J. Sullivan, M.S.W.

2 p.m.-5:30 p.m.

Advances in Psychopharmacology: An Update on the Essentials of Clinical Psychopharmacology Chairperson: Alan F. Schatzberg, M.D., Co-Chairperson: Charles B. Nemeroff, M.D.

3 p.m.-5 p.m.

New Research Young Investigators’ Poster Session 5

6 p.m.-7:30 p.m.

Convocation

L7. Psychiatry and the Medical Consumer Movement Rodger McFarlane,APA’s William C. Menninger Memorial Lecture and Patient Advocacy Award Lecture